Histamine H4-receptors inhibit mast cell renin release in ischemia/reperfusion via protein kinase C ε-dependent aldehyde dehydrogenase type-2 activation - Wikidata - awgldk - TriplyDB

Histamine H4-receptors inhibit mast cell renin release in ischemia/reperfusion via protein kinase C ε-dependent aldehyde dehydrogenase type-2 activation

Histamine H4-receptors inhibit mast cell renin release in ischemia/reperfusion via protein kinase C ε-dependent aldehyde dehydrogenase type-2 activation

http://www.wikidata.org/entity/Q33603610

about

Pharmacological treatment options for mast cell activation disease International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.Selective cytoprotective effect of histamine on doxorubicin-induced hepatic and cardiac toxicity in animal models.Novel histamine H4 receptor ligands and their potential therapeutic applications: an update.Regulation of the Cardiovascular System by Histamine.Histamine Release from Mast Cells and Basophils.

P2860

Q26748784-D2D07BB7-8FB9-4C67-BF74-044EF1337A38 Q26827568-B79E01BC-AAB7-4504-8CD3-09BC6E1E140B Q34847699-33FC9BAF-6CCA-401C-9EA2-9566CF9DD87A Q37164327-5F8F6C97-7521-44A4-94D0-F9D3554EE707 Q38248956-E349083C-3ABD-42F7-8FC7-C4BCA0C22617 Q39006801-C30CCD1A-085A-428A-AB97-A154F8294670 Q40282553-AD036F0A-F011-4C87-AA3B-2205A201BB52

P2860

Histamine H4-receptors inhibit mast cell renin release in ischemia/reperfusion via protein kinase C ε-dependent aldehyde dehydrogenase type-2 activation

http://www.wikidata.org/entity/Q33603610

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Histamine H4-receptors inhibit ...... ehydrogenase type-2 activation

@ast

Histamine H4-receptors inhibit ...... ehydrogenase type-2 activation

@en

type

label

Histamine H4-receptors inhibit ...... ehydrogenase type-2 activation

@ast

Histamine H4-receptors inhibit ...... ehydrogenase type-2 activation

@en

prefLabel

Histamine H4-receptors inhibit ...... ehydrogenase type-2 activation

@ast

Histamine H4-receptors inhibit ...... ehydrogenase type-2 activation

@en

P1433

Q33603610-5009F732-9268-4A99-B8ED-97F68B80B050

P1476

Q33603610-59A5921B-5F5A-48AF-88C2-500853BE7159

P2093

Q33603610-164F9FF7-67A1-4470-A108-EDA64A7FE878

Q33603610-389122EF-DEB3-4D3A-9F9F-FFAE94698ACD

Q33603610-43FEE587-C43D-4E3C-9B55-1840CBDE9C94

Q33603610-57C97432-0440-40D2-B1E3-64E42D6B7B23

Q33603610-6F531FED-AE4B-4A3C-BE60-D6F251CDBF75

Q33603610-6FD48151-8125-4475-A600-420E0394CD4B

Q33603610-99462E1B-7367-4100-A834-5E57F7BFDCCA

Q33603610-F203E35C-1571-4ACC-A322-16CCEB05031D

P2860

Q33603610-04D16DE0-35D5-4769-BAB3-5F74CD4C51BC

Q33603610-13841419-700D-483D-87B6-652514E6C769

Q33603610-171B1602-38CB-4137-952A-BAC6A4A2BB6B

Q33603610-205C86EE-D23A-4C7D-B322-2D631711F53C

Q33603610-25FBDEF7-A28D-409F-BCC3-DDE3CB3C6D50

Q33603610-2BDBD178-F3DC-4675-B7C8-3853CF93FEE5

Q33603610-2C19432B-A4D5-4FA5-A2C9-A0802A2DECDE

Q33603610-2F3D13D5-0D6A-4A93-9619-0A9035FEC4E3

Q33603610-350EC528-DC1B-4F1A-BFC5-4181BEE5DD14

Q33603610-37312695-7482-44A3-9D3F-1118AEF50E9E

P304

Q33603610-EC9F13B1-7655-4A82-AE94-BB95DA729D44

P31

Q33603610-339773A4-431A-41B0-8785-FA5D6FF457EB

P356

Q33603610-E420AD3C-D33D-46AE-B4C1-A2E74937D977

P407

Q33603610-FD8BDA97-2C4F-42E7-ABC1-75287A25FA35

P433

Q33603610-292621A3-1CD6-481C-89FA-57DD6102C06B

P478

Q33603610-91A9BFE0-F30E-43E2-9CD3-05716FA4D15D

P50

Q33603610-1D207AAF-6988-4DED-A159-D20DC9F87387

P577

Q33603610-FA14A508-D0D8-4C13-B65C-0FDB0EF2D2F3

P698

Q33603610-04CC18DA-DF2A-40E2-A895-91F8AD5AE3D8

P932

Q33603610-C17ED160-9690-4D97-A9F1-539E8672F56D

P356

JPET.114.214122

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Histamine H4-receptors inhibit ...... ehydrogenase type-2 activation

@en

P2093

Alice Marino

http://www.w3.org/2001/XMLSchema#string

Ken-ichi Takano

http://www.w3.org/2001/XMLSchema#string

Kengo Tomita

http://www.w3.org/2001/XMLSchema#string

Kenichiro Koda

http://www.w3.org/2001/XMLSchema#string

Mariselis Salazar-Rodriguez

http://www.w3.org/2001/XMLSchema#string

Noel Y-K Chan

http://www.w3.org/2001/XMLSchema#string

Roberto Levi

http://www.w3.org/2001/XMLSchema#string

Silvia Aldi

http://www.w3.org/2001/XMLSchema#string

P2860

Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts

Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart

A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function

Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection.

Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure.

Cloning, expression, and pharmacological characterization of a novel human histamine receptor.

Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload.

The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?

Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?

P304

508-517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.114.214122

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P50

Robin L. Thurmond

P577

2014-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24696042

http://www.w3.org/2001/XMLSchema#string

P932

4019319

http://www.w3.org/2001/XMLSchema#string